Search hospitals > North Carolina > Chapel Hill
Unc Aids Crs
Claim this profileChapel Hill, North Carolina 27514
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Antiretroviral Therapy
Conducts research for Infections and Infestations
Conducts research for HIV
Conducts research for Skin and Soft Tissue Infections
105 reported clinical trials
1 medical researcher
Summary
Unc Aids Crs is a medical facility located in Chapel Hill, North Carolina. This center is recognized for care of Human Immunodeficiency Virus Infection, Antiretroviral Therapy, Infections and Infestations, HIV, Skin and Soft Tissue Infections and other specialties. Unc Aids Crs is involved with conducting 105 clinical trials across 68 conditions. There are 1 research doctors associated with this hospital, such as David A. Wohl, MD.Area of expertise
1Human Immunodeficiency Virus Infection
Global LeaderHBeAg positive
HBeAg negative
HIV-1 positive
2Antiretroviral Therapy
Global LeaderTop PIs
Clinical Trials running at Unc Aids Crs
HIV
HIV/AIDS
Tenofovir
CH505 TF chTrimer Vaccine
for HIV
A5422 is a phase 1, randomized, double-blind, placebo-controlled clinical trial to assess the safety, tolerability, and immunogenicity of a vaccination with stabilized CH505 TF chTrimer admixed with 3M-052-AF + Aluminum hydroxide (Alum), to assess the effect of CH505 TF chTrimer vaccine as a therapeutic vaccine in adults living with HIV-1 on suppressive antiretroviral therapy (ART) with the aim of inducing new HIV-1 Envelope (Env) B-cell neutralizing immune responses. Participants will be on study for up to 100 weeks (52 weeks on study treatment plus 48 weeks follow-up).
Recruiting0 awards Phase 13 criteria
Triple Immune Regimen
for HIV
The purpose of this study is to evaluate the safety, tolerability, and efficacy of therapeutic vaccination with chimpanzee adenovirus ChAdOx1- and poxvirus modified vaccinia Ankara (MVA)-vectored conserved mosaic T-cell vaccines in a sequential regimen with the toll-like receptor 7 (TLR7) agonist vesatolimod (VES) and two broadly neutralizing antibodies (bNAbs) compared to placebo, to induce HIV-1 control during analytic treatment interruption (ATI).
Recruiting0 awards Phase 1 & 214 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Unc Aids Crs?
Unc Aids Crs is a medical facility located in Chapel Hill, North Carolina. This center is recognized for care of Human Immunodeficiency Virus Infection, Antiretroviral Therapy, Infections and Infestations, HIV, Skin and Soft Tissue Infections and other specialties. Unc Aids Crs is involved with conducting 105 clinical trials across 68 conditions. There are 1 research doctors associated with this hospital, such as David A. Wohl, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.